Pages that link to "Q36140582"

The following pages link to A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors (Q36140582):

Displaying 35 items.

• The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling (Q24295243) (← links)
• ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome (Q24313063) (← links)
• Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics. (Q33425333) (← links)
• Anti-Tumor Effect in Human Lung Cancer by a Combination Treatment of Novel Histone Deacetylase Inhibitors: SL142 or SL325 and Retinoic Acids (Q33747841) (← links)
• Melanoma: a model for testing new agents in combination therapies (Q33863916) (← links)
• Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation (Q34739990) (← links)
• Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine (Q34935239) (← links)
• Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"? (Q35001132) (← links)
• Retinoic Acid Drives Aryl Hydrocarbon Receptor Expression and Is Instrumental to Dioxin-Induced Toxicity during Palate Development (Q35579852) (← links)
• Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro (Q35617537) (← links)
• Epigenetic regulation by RARα maintains ligand-independent transcriptional activity (Q35633556) (← links)
• In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis (Q35930494) (← links)
• Human TNFα-induced protein 3-interacting protein 1 (TNIP1) promoter activation is regulated by retinoic acid receptors (Q36532697) (← links)
• PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma (Q36658116) (← links)
• Retinoic acid influences neuronal migration from the ganglionic eminence to the cerebral cortex (Q37066125) (← links)
• Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. (Q37096490) (← links)
• Thyroid hormone activation of retinoic acid synthesis in hypothalamic tanycytes (Q37105492) (← links)
• Epigenetics and dermatological disease (Q37346201) (← links)
• The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells (Q37381700) (← links)
• Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications (Q37512907) (← links)
• Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia (Q37783631) (← links)
• Towards systematic functional characterization of cancer genomes (Q37890867) (← links)
• Molecular basis of differentiation therapy for soft tissue sarcomas (Q38588243) (← links)
• The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC. (Q38772843) (← links)
• Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. (Q38876333) (← links)
• Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition (Q39253408) (← links)
• The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ERα, and is an independent prognostic factor in node-negative breast cancer. (Q39433453) (← links)
• BCR–ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients (Q39656321) (← links)
• Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis (Q42234572) (← links)
• Combination therapies improve the anticancer activities of retinoids in neuroblastoma (Q43134812) (← links)
• Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients (Q47715440) (← links)
• Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells (Q51334063) (← links)
• Histone deacetylase inhibitors in cancer therapy (Q82233643) (← links)
• Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer (Q84784256) (← links)
• The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer (Q89542534) (← links)